Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis.

The Journal of pediatrics - 1 Sept 2004

Borowitz Drucy, Baker Susan S, Duffy Linda, Baker Robert D, Fitzpatrick Laura, Gyamfi Joyce, Jarembek Kerry

Abstract excerpt

OBJECTIVE: To test the hypothesis that some patients with cystic fibrosis (CF) are misclassified as pancreatic insufficient, using fecal elastase-1 (FE-1) to define pancreatic status. STUDY DESIGN: Subjects with CF at 33 CF centers filled out questionnaires and submitted a stool specimen that was analyzed for FE-1. Subjects taking pancreatic enzyme supplements (PES) were asked to discontinue them and perform a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child, Preschool
Share to Cystic Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Exocrine Pancreatic Insufficiency

Share to Infant

Share to Pancreatic Elastase

Share to Registries

Source

Identifiers

PMID: 15343184
DOI: 10.1016/j.jpeds.2004.04.049

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis.PMID 15343184Read ↗

Fecal elastase: pancreatic status verification and influence on nutritional status in children with cystic fibrosis.Semantic proximity Read ↗

Changes in fecal elastase-1 following initiation of CFTR modulator therapy in pediatric patients with cystic fibrosis.Semantic proximity Read ↗

Longitudinal follow-up of exocrine pancreatic function in pancreatic sufficient cystic fibrosis patients using the fecal elastase-1 test.Semantic proximity Read ↗

Use of monoclonal faecal elastase-1 concentration for pancreatic status assessment in cystic fibrosis patients.Semantic proximity Read ↗

Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis.Semantic proximity Read ↗

Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations.Semantic proximity Read ↗

Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review.Semantic proximity Read ↗

Evolution of pancreatic function during the first year in infants with cystic fibrosis.Semantic proximity Read ↗

Improving Pancreatic Function With Elexacaftor/Tezacaftor/Ivacaftor.Semantic proximity Read ↗

CFTR modulators increase risk of acute pancreatitis in pancreatic insufficient patients with cystic fibrosis.Semantic proximity Read ↗

Detection of human elastase isoforms by the ScheBo Pancreatic Elastase 1 Test.Semantic proximity Read ↗

Faecal elastase 1 levels in premature and full term infantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.